🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 552641102
- Market Cap
- Micro Cap
- IPO
- 7/28/2022 · $5.00/share
Business: MAIA Biotechnology, Inc. is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. The Company’s lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of patients with telomerase-positive cancers.
Company Contact
- CEO
- Vlad Vitoc
- CFO
- Joseph F. McGuire
- Headquarters
- 444 West Lake Street, Suite 1700, Chicago, IL 06060
- Phone
- 312-416-8592
- Investor Relations
- 872-270-3518 · ir@maiabiotech.com